• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Atrium Innovations Inc

A8T:GR

Ticker Delisted

Snapshot for Atrium Innovations Inc (A8T)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: 10.622 - 16.888 1-Yr Rtn: -

Stock Chart for A8T

No chart data available.
  • A8T:GR 15.926
  • 1M
  • 1Y
0.000
Interactive A8T Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A8T

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) 12.8953
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) 1.6800
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A8T

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for A8T

Atrium Innovations Inc. develops, manufactures, and markets products for the cosmetics, pharmaceutical, chemical, and nutrition industries. The Company focuses primarily on growing segments of the health and personal care markets. Atrium markets a broad portfolio of active ingredients, specialty chemicals, and health and nutrition finished products.

Peter LutherPresident/CEOPierre FitzgibbonPresident/CEO
Paul HannemaExec VP/Head:European OpsSerge YelleExec VP:Strategy & Bus Dev
More Company Profile & Key Executives for A8T

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil